- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
目 录
中药影响金黄色葡萄球菌对氟喹诺酮类药物的耐药突变选择
1
窗MSW 及耐药性变化的研究„„„„„„„„„„„„„
1.1 中文摘要„„„„„„„„„„„„„„„„„„„„„1
1.2 英文摘要„„„„„„„„„„„„„„„„„„„„„3
1.3 前言„„„„„„„„„„„„„„„„„„„„„„„5
第一部分 中药联合左氧氟沙星影响左氧氟沙星对金黄色葡
1.4
萄球菌的耐药突变选择窗MSW 的体外研究
1 材料与方法„„„„„„„„„„„„„„„„„„„8
2 结果„„„„„„„„„„„„„„„„„„„„„„18
3 讨论„„„„„„„„„„„„„„„„„„„„„„18
第二部分 中药联合左氧氟沙星影响左氧氟沙星对金黄色葡
1.5
萄球菌的耐药突变选择窗MSW 的体内研究
1 材料与方法„„„„„„„„„„„„„„„„„„„7
2 结果„„„„„„„„„„„„„„„„„„„„„„18
3 讨论„„„„„„„„„„„„„„„„„„„„„„19
1.6 结论„„„„„„„„„„„„„„„„„„„„„„„21
1.7 参考文献„„„„„„„„„„„„„„„„„„„„„25
2 致谢„„„„„„„„„„„„„„„„„„„„„„„26
耐药突变选择窗理论的研究与意义 (综述)„„„„„29
3
中药影响金黄色葡萄球菌对氟喹诺酮类药物的耐药突变选
择窗MSW 及耐药性变化的研究
摘 要
目的:探讨中药制剂与左氧氟沙星联合应用对金黄色葡萄球菌的抑菌
作用,并考察其对左氧氟沙星的耐药突变选择窗(MSW)的影响,为临
床减少氟喹诺酮类抗菌药物的耐药产生提供一种全新的治疗策略。方
法:体外研究尝试用琼脂平板二倍稀释法测定双黄连粉针,喜炎平注
射剂,大蒜素注射剂3 种中药制剂对标准金黄色葡萄球菌的最低抑菌
浓度(MIC)、防耐药变异浓度(MPC)并计算其治疗指数(SI)。再将
以上中药制剂与左氧氟沙星联用以考察以上中药制剂是否能缩窄左
氧氟沙星的MSW,并筛选出抗菌效果较好且对降低左氧氟沙星的MSW
影响最大的中药制剂做进一步的体内研究,以考察中药制剂是否能在
体内降低左氧氟沙星的 MSW 。结果:双黄连的 MSW 为 1.905~
14.737mg/ml,SI 为7.736;大蒜素的MSW 为5.960~38.500 μg/ml,
SI 为6.460。喜炎平的MSW 未测得。双黄连与左氧氟沙星联用在体外
可将左氧氟沙星的SI 显著降低,而大蒜素对左氧氟沙星的SI 和MSW
几乎没有作用。体内实验表明左氧氟沙星+双黄连组的耐药发生率低
于单用左氧氟沙星组。结论:3 种中药注射剂对金黄色葡萄球菌有一
定的抑制作用,体外实验显示双黄连可明显降低左氧氟沙星的 SI。
体内实验表明左氧氟沙星+双黄连组的耐药发生率低于单用左氧氟沙
星组。
关键词:中药制剂;左氧氟沙星;MSW
Chinese medicine preparations associated with levofloxacin
resistance changes in vivo and in Staphylococcus aureus
Abstract:
bjective: Explore the inhibitory role of traditional Chinese medicine
preparation of Staphylococcus aureus in combination with levofloxacin,
investigated levofloxacin resistance mutations to select the window
(MSW), to reduce the resistance of fluoroquinolones for clinical provide
a newtherapeutic strategies.
Methods : Try in vitro st
文档评论(0)